Cargando…

SARS-CoV-2 re-infection: development of an epidemiological definition from India

The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Aparna, Anand, Tanu, Agarwal, Anup, Singh, Harpreet, Chatterjee, Pranab, Narayan, Jitendra, Rana, Salaj, Gupta, Nivedita, Bhargava, Balram, Panda, Samiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027559/
https://www.ncbi.nlm.nih.gov/pubmed/33766185
http://dx.doi.org/10.1017/S0950268821000662
_version_ 1783675836172337152
author Mukherjee, Aparna
Anand, Tanu
Agarwal, Anup
Singh, Harpreet
Chatterjee, Pranab
Narayan, Jitendra
Rana, Salaj
Gupta, Nivedita
Bhargava, Balram
Panda, Samiran
author_facet Mukherjee, Aparna
Anand, Tanu
Agarwal, Anup
Singh, Harpreet
Chatterjee, Pranab
Narayan, Jitendra
Rana, Salaj
Gupta, Nivedita
Bhargava, Balram
Panda, Samiran
author_sort Mukherjee, Aparna
collection PubMed
description The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India.
format Online
Article
Text
id pubmed-8027559
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-80275592021-04-08 SARS-CoV-2 re-infection: development of an epidemiological definition from India Mukherjee, Aparna Anand, Tanu Agarwal, Anup Singh, Harpreet Chatterjee, Pranab Narayan, Jitendra Rana, Salaj Gupta, Nivedita Bhargava, Balram Panda, Samiran Epidemiol Infect From the Field The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India. Cambridge University Press 2021-03-26 /pmc/articles/PMC8027559/ /pubmed/33766185 http://dx.doi.org/10.1017/S0950268821000662 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle From the Field
Mukherjee, Aparna
Anand, Tanu
Agarwal, Anup
Singh, Harpreet
Chatterjee, Pranab
Narayan, Jitendra
Rana, Salaj
Gupta, Nivedita
Bhargava, Balram
Panda, Samiran
SARS-CoV-2 re-infection: development of an epidemiological definition from India
title SARS-CoV-2 re-infection: development of an epidemiological definition from India
title_full SARS-CoV-2 re-infection: development of an epidemiological definition from India
title_fullStr SARS-CoV-2 re-infection: development of an epidemiological definition from India
title_full_unstemmed SARS-CoV-2 re-infection: development of an epidemiological definition from India
title_short SARS-CoV-2 re-infection: development of an epidemiological definition from India
title_sort sars-cov-2 re-infection: development of an epidemiological definition from india
topic From the Field
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027559/
https://www.ncbi.nlm.nih.gov/pubmed/33766185
http://dx.doi.org/10.1017/S0950268821000662
work_keys_str_mv AT mukherjeeaparna sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT anandtanu sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT agarwalanup sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT singhharpreet sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT chatterjeepranab sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT narayanjitendra sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT ranasalaj sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT guptanivedita sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT bhargavabalram sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia
AT pandasamiran sarscov2reinfectiondevelopmentofanepidemiologicaldefinitionfromindia